# New European Standards of care Aim to Transform HIV Management and Improve Patient Outcomes
A comprehensive new framework for HIV prevention, testing, and treatment has been released by the European Center for Disease Prevention and Control (ECDC) and the European AIDS Clinical Society (EACS), setting enterprising new standards for care across the region. The updated guidelines focus on initiating antiretroviral therapy (ART) immediatly upon diagnosis and proactively managing co-occurring health conditions, marking a meaningful evolution in HIV care.
An estimated 2.3 million people are living with HIV in the WHO European Region, including 778,000 in the EU/EEA. These new standards aim to enhance the quality of care for this population, building upon existing protocols for pre-exposure prophylaxis (PrEP) and HIV testing.
Immediate Treatment: A New Standard of Care
Table of Contents
the latest guidance reinforces the growing consensus that all individuals diagnosed with HIV should be offered treatment without delay.The Commencement of ART module establishes a target of initiating therapy quickly, ideally within seven days of diagnosis. This rapid initiation not only improves individual health outcomes but also serves as a crucial tool in preventing further transmission of the virus.
“Evidence has shown that those who begin HIV treatment late, especially those with weakened immune systems (CD4 ≤ 350 cells/μL), are more likely to face serious health risks, including early mortality, compared to those who are diagnosed and treated early,” a senior official stated.
Did you know?-Early ART initiation can reduce the risk of HIV transmission to sexual partners to effectively zero,a concept known as “Undetectable = Untransmittable” (U=U).
Addressing the Growing Burden of Co-morbidities
As effective HIV treatments extend life expectancy, individuals living with HIV are increasingly facing a higher incidence of non-communicable diseases (NCDs). These include cardiovascular disease (CVD), diabetes, various cancers, chronic kidney, liver, and lung diseases, as well as mental and neurocognitive disorders.
Recognizing this evolving health landscape, the module on HIV and Co-morbidities provides a structured approach to integrated care. It outlines essential protocols for regular screening and preventative measures targeting conditions like CVD, specific cancers, and mental health disorders, with the ultimate goal of supporting healthy aging and improving overall well-being.
Pro tip:-Regular screenings for NCDs are vital for people living with HIV, even if they feel healthy. Early detection allows for timely intervention and better management of these conditions.
A Collaborative, Person-Centred Approach
The progress of these standards was a collaborative effort involving clinicians, public health experts, and crucially, community representatives representing people living with HIV. This person-centred approach ensures the guidance is grounded in the latest scientific evidence while remaining practical, equitable, and empowering for those it is indeed designed to serve.
The standards are intended to serve as a benchmark for high-quality, holistic care, providing healthcare systems with a tool to audit and improve their services. Furthermore, they empower individuals living with HIV by clearly defining the level of care they should expect.
Why were these standards developed? The European Centre for Disease Prevention and Control (ECDC) and the European AIDS Clinical Society (EACS) recognized the need for updated guidelines to reflect advancements in HIV treatment and the changing health needs of people living with HIV. The goal is to improve health outcomes and reduce transmission rates across Europe.
Who is affected by these standards? These standards impact approximately 2.3 million people living with HIV in the WHO European region,including 778,000 in the EU/EEA. They also affect healthcare providers, public health officials, and organizations involved in HIV prevention and care.
What do the new standards entail? The key changes include initiating antiretroviral therapy (ART
